Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-23-291271
Filing Date
2023-12-08
Accepted
2023-12-08 09:00:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC TO-C d621380dsctoc.htm SC TO-C 20438
2 EX-99.2 d621380dex992.htm EX-99.2 4486
  Complete submission text file 0001193125-23-291271.txt   26413
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filed by) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Subject) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-88275 | Film No.: 231474046
SIC: 2834 Pharmaceutical Preparations